🔎 Trials Near Me

Gara Jalqabaatti › Myasthenia Gravis › North Carolina

Qorannoo klinikaalii Myasthenia Gravis North Carolina keessatti

Qorannoo 14 Myasthenia Gravis f North Carolina keessatti hirmaatuu jiru.

Magaalota North Carolina keessatti

Takkalaa qorannoo (Ingiliffa)

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  • Velocity Clinical Research, Inc., Raleigh
  • Atrium Health Wake Forest Baptist, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07217587

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  • Cinical Study Site, Fayetteville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07647510

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

  • University of North Carolina at Chapel Hill-170 Manning Dr., Chapel Hill
  • Duke Early Phase Clinical Research Unit - PPDS, Durham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07294170

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

  • University of North Caroline at Chapel Hill-170 Manning Dr, Chapel Hill
  • Duke Early Phase Clinical Research Unit - PPDS, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07284420

A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

  • TG Therapeutics Investigational Trial Site, New Bern
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07673744

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  • UNC Hospitals - PARENT, Chapel Hill
  • Atrium Health Wake Forest Baptist, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06463587

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

  • The University of North Carolina at Chapel Hill, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06414954

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1020, Chapel Hill
  • Site Number - 1013, Durham
  • Site Number - 1044, Raleigh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07039916

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  • Duke University School of Medicine, Durham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT04951622

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

  • University of North Carolina Hospitals - Neurology Clinic, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT06456580

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

  • Research Site, Raleigh
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Elb-2026 · NCT07221838

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  • Clinical Trial Site, Chapel Hill
  • Clinical Trial Site, Charlotte
  • Clinical Trial Site, Durham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Gur-2026 · NCT04202341

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

  • University of North Carolina at Chapel Hill, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 2 hanga 18 · Saalaa hunda · Haaromfame 18-Gur-2026 · NCT04833894

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

  • Duke University, Durham
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Elb-2025 · NCT05564936

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.